Description
A Breakthrough in Dry Eye Treatment
OptiLIGHT by Lumenis is the first and only FDA-approved IPL therapy for the treatment of Dry Eye Disease caused by Meibomian Gland Dysfunction (MGD) – the leading cause of dry eye.
Powered by patented OPT™ technology, OptiLIGHT delivers targeted, non-invasive light therapy to reduce inflammation, restore meibomian gland function, and improve tear film stability.
Key Benefits:
• Clinically proven results
• Safe, gentle, and comfortable for patients
• User-friendly design tailored for eye care professionals
• Compatible with OptiPLUS for enhanced therapeutic and aesthetic outcomes
Redefine dry eye management – with OptiLIGHT.
Video: Lumenis OptiLight
